Equity Partners IV Lp Montreux serves as Executive at EPIRUS Biopharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Equity Partners IV Lp Montreux has executed 7 insider transactions totaling $1.5M, demonstrating a bearish approach to their equity position. Their most recent transaction on Feb 6, 2015 involved selling 100,000 shares valued at $501.0K.
Equity Partners IV Lp Montreux currently holds 1,671,400 shares of EPIRUS Biopharmaceuticals, Inc. (EPRS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Equity Partners IV Lp Montreux has been a net seller of EPRS stock. They have purchased $0 and sold $1.5M worth of shares.
Equity Partners IV Lp Montreux's most recent insider trade was on Feb 6, 2015, when they sold 100,000 shares at $5.01 per share.
Get notified when new Form 4 filings are submitted
| $4.97 |
| Discretionary |
| Feb 4, 2015 | EPRS | $28.1K | Sale | 5,684 | $4.95 | Discretionary |
| Feb 3, 2015 | EPRS | $234.5K | Sale | 47,000 | $4.99 | Discretionary |
| Jan 26, 2015 | EPRS | $249.2K | Sale | 38,516 | $6.47 | Discretionary |
| Jan 23, 2015 | EPRS | $52.7K | Sale | 8,400 | $6.27 | Discretionary |
| Jan 22, 2015 | EPRS | $89.0K | Sale | 14,130 | $6.30 | Discretionary |